Inogen (NASDAQ:INGN – Get Free Report) is projected to post its quarterly earnings results after the market closes on Tuesday, February 25th. Analysts expect Inogen to post earnings of ($0.56) per share and revenue of $73.90 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Inogen Stock Down 3.6 %
Inogen stock opened at $9.91 on Monday. The company has a market cap of $236.04 million, a price-to-earnings ratio of -4.40 and a beta of 1.02. The firm’s fifty day moving average is $10.17 and its 200 day moving average is $10.29. Inogen has a 52-week low of $5.82 and a 52-week high of $13.33.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Thursday, January 30th. StockNews.com upgraded shares of Inogen from a “hold” rating to a “buy” rating in a research report on Monday, February 10th.
Inogen Company Profile
Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Featured Articles
- Five stocks we like better than Inogen
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Where Do I Find 52-Week Highs and Lows?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 5 discounted opportunities for dividend growth investors
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.